TRSSF: AI 评分 43/100 — AI 分析 (4月 2026)

TerrAscend Corp. cultivates, processes, and sells medical and adult-use cannabis in Canada and the United States. The company operates dispensaries under brands like Apothecarium and Cookies, and owns brands like Gage Cannabis and Kind Tree.

Key Facts: AI Score: 43/100 Sector: Healthcare

公司概况

概要：

TerrAscend Corp. is a North American cannabis company focused on cultivation, processing, and retail sales of medical and adult-use cannabis. With a portfolio of recognized brands and a growing dispensary network, TerrAscend aims to establish a strong presence in key cannabis markets across the United States and Canada.

TRSSF是做什么的？

TerrAscend Corp., incorporated in 2017 and headquartered in Mississauga, Canada, operates as a vertically integrated cannabis company, cultivating, processing, and selling medical and adult-use cannabis in both Canada and the United States. The company's operations span the entire cannabis value chain, from cultivation and processing to retail distribution. TerrAscend produces and distributes hemp-derived wellness products to retail locations and manufactures cannabis-infused artisan edibles. The company's retail footprint includes dispensaries operating under the Apothecarium brand in California and Pennsylvania, as well as Cookies dispensaries in Michigan and Toronto. TerrAscend owns various synergistic brands, including Gage Cannabis, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc., allowing it to cater to a diverse range of consumer preferences and market segments. As of July 26, 2022, TerrAscend operated 27 dispensaries, solidifying its presence in key cannabis markets.

TRSSF的投资论点是什么？

TerrAscend Corp. presents a notable market position within the expanding North American cannabis market. The company's vertically integrated business model, encompassing cultivation, processing, and retail, allows for greater control over the supply chain and enhanced profitability. With a gross margin of 51.3%, TerrAscend demonstrates strong operational efficiency. Growth will be driven by expansion of its dispensary network and increasing brand recognition. However, the company's negative profit margin of -32.1% and a high beta of 2.00 indicate significant risk and volatility. Investors should monitor progress toward profitability and navigate the evolving regulatory landscape.

TRSSF在哪个行业运营？

TerrAscend operates in the rapidly evolving cannabis industry, characterized by increasing legalization and growing consumer acceptance. The North American cannabis market is experiencing substantial growth, driven by both medical and recreational use. Competition is intense, with numerous players vying for market share, including established cannabis companies and new entrants. TerrAscend's vertically integrated model and established brand portfolio position it to capitalize on this growth, but it must navigate regulatory complexities and compete effectively to maintain its market position.

Drug Manufacturers - Specialty & Generic

Healthcare

TRSSF有哪些增长机遇？

Expansion of Dispensary Network: TerrAscend has the opportunity to expand its retail footprint by opening new dispensaries in strategic locations. The company can leverage its existing brands, such as Apothecarium and Cookies, to attract customers and establish a strong presence in new markets. This expansion can drive revenue growth and increase market share. The timeline for this growth opportunity is ongoing, with potential for significant expansion over the next 3-5 years.
Increased Brand Recognition and Loyalty: TerrAscend can invest in marketing and branding initiatives to increase brand recognition and loyalty among consumers. By building strong brand equity, the company can differentiate itself from competitors and attract a larger customer base. This growth opportunity is ongoing, with continuous efforts to enhance brand awareness and customer engagement.
Product Innovation and Development: TerrAscend can focus on developing new and innovative cannabis products to meet evolving consumer preferences. This includes exploring new form factors, formulations, and consumption methods. By staying ahead of the curve in product innovation, the company can attract new customers and maintain its competitive edge. The timeline for new product development is typically 12-18 months.
Strategic Acquisitions and Partnerships: TerrAscend can pursue strategic acquisitions and partnerships to expand its capabilities and market reach. This includes acquiring complementary businesses, such as cultivation facilities or processing facilities, or partnering with other cannabis companies to access new markets or technologies. The timeline for acquisitions and partnerships is variable, depending on the specific opportunities that arise.
Expansion into New Geographies: TerrAscend can explore opportunities to expand its operations into new geographies, both within North America and internationally. This includes entering new states or provinces that have legalized cannabis, as well as exploring opportunities in emerging international markets. The timeline for geographic expansion is dependent on regulatory changes and market conditions.

Market capitalization of $0.60 billion reflects TerrAscend's current valuation in the cannabis market.
Gross margin of 51.3% indicates strong operational efficiency in cannabis production and sales.
Operates 27 dispensaries as of July 2022, providing a significant retail footprint across key markets.
Negative P/E ratio of -2.43 suggests the company is currently unprofitable.
Beta of 2.00 indicates high volatility compared to the broader market.

TRSSF提供哪些产品和服务？

Cultivates medical and adult-use cannabis.
Processes cannabis into various products.
Sells cannabis through its own retail dispensaries.
Distributes hemp-derived wellness products.
Manufactures cannabis-infused artisan edibles.
Operates dispensaries under the Apothecarium and Cookies brands.
Owns various synergistic brands like Gage Cannabis and Kind Tree.

TRSSF如何赚钱？

Vertically integrated model encompassing cultivation, processing, and retail.
Generates revenue through the sale of cannabis products at its dispensaries.
Distributes hemp-derived wellness products to retail locations.
Licenses brands and intellectual property.

Medical cannabis patients seeking therapeutic relief.
Adult-use cannabis consumers seeking recreational experiences.
Retail partners who sell TerrAscend's hemp-derived wellness products.

Vertically integrated operations provide control over the supply chain.
Established brands like Apothecarium and Cookies create customer loyalty.
Strategic dispensary locations provide access to key markets.
Proprietary cultivation and processing techniques ensure product quality.

什么因素可能推动TRSSF股价上涨？

Upcoming: Expansion of dispensary network into new states and provinces.
Ongoing: Increasing brand awareness and customer loyalty through marketing initiatives.
Ongoing: Product innovation and development to meet evolving consumer preferences.
Upcoming: Potential acquisitions of complementary businesses to expand capabilities.
Ongoing: Regulatory changes and legalization efforts in new jurisdictions.

TRSSF的主要风险是什么？

Ongoing: Intense competition from other cannabis companies.
Ongoing: Evolving regulatory landscape and potential changes in cannabis laws.
Potential: Fluctuations in cannabis prices affecting profitability.
Potential: Economic downturn impacting consumer spending on cannabis products.
Potential: Difficulty in obtaining financing due to the stigma surrounding the cannabis industry.

TRSSF的核心优势是什么？

Vertically integrated operations.
Established brands (Apothecarium, Cookies, Kind Tree).
Strategic dispensary locations.
Strong gross margin (51.3%).

TRSSF的劣势是什么？

Negative profit margin (-32.1%).
High beta (2.00) indicating high volatility.
Reliance on regulatory approvals.
Limited geographic diversification.

TRSSF有哪些机遇？

Expansion of dispensary network.
Increased brand recognition and loyalty.
Product innovation and development.
Strategic acquisitions and partnerships.

TRSSF面临哪些威胁？

Intense competition.
Evolving regulatory landscape.
Fluctuations in cannabis prices.
Economic downturn affecting consumer spending.

TRSSF的竞争对手是谁？

Aleafia Health Inc. — Focuses on medical cannabis and clinic network. — (AIHLF)
Columbia Care Inc. — Multi-state operator with a broad geographic footprint. — (CCHWF)
Canndescent — Premium cannabis brand focused on quality and experience. — (CKDXF)
Cresco Labs Inc. — Vertically integrated operator with a focus on branded products. — (CLAZF)
Cronos Group Inc. — Global cannabis company with a diverse portfolio of brands. — (CSWYF)

Key Metrics

MoonshotScore: 43/100

Company Profile

CEO: Ziad Ghanem
Headquarters: Mississauga, CA
Employees: 972
Founded: 2017

AI Insight

AI analysis pending for TRSSF

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does TerrAscend Corp. do?

TerrAscend Corp. is a vertically integrated cannabis company that cultivates, processes, and sells medical and adult-use cannabis in Canada and the United States. The company operates a network of retail dispensaries under the Apothecarium and Cookies brands, and also owns a portfolio of synergistic brands, including Gage Cannabis, Ilera Healthcare, and Kind Tree. TerrAscend's business model encompasses the entire cannabis value chain, from cultivation and processing to retail distribution, allowing it to control product quality and enhance profitability. The company also produces and distributes hemp-derived wellness products to retail locations and manufactures cannabis-infused artisan edibles.

What do analysts say about TRSSF stock?

Analyst coverage of TRSSF stock is limited due to its OTC listing. However, analysts generally view TerrAscend as a company with significant growth potential, driven by its vertically integrated operations, established brands, and expansion into new markets. Key valuation metrics to consider include revenue growth, gross margin, and EBITDA. Investors should carefully evaluate the risks associated with investing in OTC stocks, including limited liquidity and transparency. Analyst consensus is pending due to limited coverage.

What are the main risks for TRSSF?

The main risks for TerrAscend Corp. include intense competition from other cannabis companies, the evolving regulatory landscape and potential changes in cannabis laws, fluctuations in cannabis prices affecting profitability, and the potential for an economic downturn impacting consumer spending on cannabis products. Additionally, the company faces risks associated with operating in the OTC market, including limited liquidity and transparency. Regulatory risks are significant as cannabis remains federally illegal in the U.S., creating uncertainty and potential for adverse policy changes. Investors should carefully consider these risks before investing in TRSSF.